AzurRx BioPharma, Inc. (AZRX): Price and Financial Metrics
AZRX Price/Volume Stats
| Current price | $3.45 | 52-week high | $26.30 |
| Prev. close | $3.38 | 52-week low | $3.36 |
| Day low | $3.38 | Volume | 629,000 |
| Day high | $3.66 | Avg. volume | 628,703 |
| 50-day MA | $5.85 | Dividend yield | N/A |
| 200-day MA | $9.42 | Market Cap | 32.17M |
AZRX Stock Price Chart Interactive Chart >
AzurRx BioPharma, Inc. (AZRX) Company Bio
AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. The company's therapeutic products are administered to patients as oral non-systemic biologics. Its lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency for cystic fibrosis and chronic pancreatitis patients. The company was incorporated in 2014 and is headquartered in Delray Beach, Florida.
AZRX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -65.84% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -6.73% |
| 2019 | -14.05% |
Loading social stream, please wait...